The effect of progestins in combined oral contraceptives on serum lipids with special reference to high-density lipoproteins
- 1 March 1982
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 142 (6) , 766-772
- https://doi.org/10.1016/s0002-9378(16)32486-3
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Oral Contraceptives and Cardiovascular DiseaseNew England Journal of Medicine, 1981
- Oral Contraceptives and Cardiovascular DiseaseNew England Journal of Medicine, 1981
- Risk of Myocardial Infarction in Relation to Current and Discontinued Use of Oral ContraceptivesNew England Journal of Medicine, 1981
- MENOPAUSAL OESTROGEN THERAPY AND PROTECTION FROM DEATH FROM ISCHAEMIC HEART DISEASEThe Lancet, 1981
- COMPARISON OF EFFECTS OF DIFFERENT COMBINED ORAL-CONTRACEPTIVE FORMULATIONS ON CARBOHYDRATE AND LIPID METABOLISMThe Lancet, 1979
- Serum High-Density-Lipoprotein Cholesterol in Women Using Oral Contraceptives, Estrogens and ProgestinsNew England Journal of Medicine, 1978
- THROMBOEMBOLISM AND ŒSTROGEN THERAPYThe Lancet, 1967
- Effect of posture on the plasma cholesterol level.BMJ, 1966
- Influence of sex and sex hormones upon the development of atherosclerosis and upon the lipoproteins of plasmaJournal of Chronic Diseases, 1955
- The George E. Brown Memorial LectureCirculation, 1953